Llwytho...
Bevacizumab in Glaucoma: Where do We Stand?
The use of antivascular endothelial growth factors such as bevacizumab and ranibizumab has brought about a revolution in management protocols of various ophthalmic disorders. A lot has been written about these agents, still lacunae exist in our understanding due to paucity of randomized control tria...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Curr Glaucoma Pract |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Jaypee Brothers Medical Publishers
2012
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161771/ https://ncbi.nlm.nih.gov/pubmed/28028350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10008-1110 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|